No Data
No Data
Standard BioTools(LAB.US) 10% Shareholder Buys US$260K in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 100K shares of common stock on May 23, 2024 at an average price of $2.6 for a total value of $260K. This transac
Express News | Standard BioTools Purchases The Carterra LSA-XT System; No Financial Terms Disclosed
Express News | Standard BioTools Purchases the Carterra® Lsa-Xt System to Accelerate Data Delivery and Provide Greater Validation to Somascan Customers
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
Standard BioTools(LAB.US) 10% Shareholder Buys US$1.54 Million in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 600K shares of common stock on May 20, 21, 22, 2024 at an average price of $2.5697 for a total value of $1.54 mi
Standard BioTools to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ("Standard BioTools") (NASDAQ:LAB) today announced that its management team will participate in the following investor conferences in
No Data
TrytosaveabitOP : Grrrr! And again no FINANCIAL details yet! Grrrr! Hehehe